{"id":11557,"date":"2023-05-20T23:41:17","date_gmt":"2023-05-21T03:41:17","guid":{"rendered":"https:\/\/ifintechworld.com\/uncategorized\/curevac-files-expanded-patent-lawsuit-against-pfizer-biontech-over-mrna-technology\/"},"modified":"2023-05-20T23:41:18","modified_gmt":"2023-05-21T03:41:18","slug":"curevac-files-expanded-patent-lawsuit-against-pfizer-biontech-over-mrna-technology","status":"publish","type":"post","link":"https:\/\/ifintechworld.com\/?p=11557","title":{"rendered":"CureVac files expanded patent lawsuit against Pfizer\/BioNTech over mRNA technology"},"content":{"rendered":"
\n
\n<\/u>3\/3<\/span><\/p>\n

\u00a9 Reuters. FILE PHOTO: A vial labelled “CureVac COVID-19 Vaccine” is seen in this illustration taken January 16, 2022. REUTERS\/Dado Ruvic\/Illustration<\/span>
\n<\/i>
\n2\/3<\/span><\/u>\n<\/div>\n

(Reuters) – CureVac NV said on Friday it had filed an expanded patent infringement claim against Pfizer <\/span><\/span> Inc (NYSE:) and BioNTech over the use of mRNA technology and that a U.S. court had granted its request to transfer the trial.<\/p>\n

The company said it filed a counterclaim alleging that Pfizer and its German partner BioNTech infringed on nine of its patents, broader than its original claim of three patents.<\/p>\n

In July 2022, CureVac had filed a patent lawsuit against BioNTech over the use of mRNA technology in the companies’ COVID-19 vaccine. <\/p>\n

The transfer of the trial to the Eastern District of Virginia from the Federal District Court of Massachusetts is expected to accelerate progress of the case and allow for a likely 2024 trial date, CureVac said on Friday. <\/p>\n

Pfizer and BioNTech did not immediately respond to requests for comment.\u00a0<\/p>\n

Pfizer and BioNTech in response had filed a complaint with the U.S. District Court in Massachusetts, seeking a judgment that they did not infringe U.S. patents held by CureVac.<\/p>\n

The companies have previously told the court that their COVID vaccine Comirnaty does not work in the same way as CureVac’s patented technology.<\/p>\n

Pfizer and BioNTech are also facing patent infringement lawsuits from other companies. <\/p>\n<\/div>\n

Read the full article here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

3\/3 \u00a9 Reuters. FILE PHOTO: A vial labelled “CureVac COVID-19 Vaccine” is seen in this illustration taken January 16, 2022. REUTERS\/Dado Ruvic\/Illustration 2\/3 (Reuters) – CureVac NV said on Friday it had filed an expanded patent infringement claim against Pfizer Inc (NYSE:) and BioNTech over the use of mRNA technology and that a U.S. court […]<\/p>\n","protected":false},"author":1,"featured_media":11558,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"video","meta":{"footnotes":""},"categories":[1],"tags":[83],"class_list":["post-11557","post","type-post","status-publish","format-video","has-post-thumbnail","hentry","category-uncategorized","tag-featured","post_format-post-format-video"],"yoast_head":"\nCureVac files expanded patent lawsuit against Pfizer\/BioNTech over mRNA technology | iFintechWorld<\/title>\n<meta name=\"description\" content=\"3\/3 \u00a9 Reuters. FILE PHOTO: A vial labelled "CureVac COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. REUTERS\/Dado Ruvic\/Illustration\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ifintechworld.com\/?p=11557\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CureVac files expanded patent lawsuit against Pfizer\/BioNTech over mRNA technology | iFintechWorld\" \/>\n<meta property=\"og:description\" content=\"3\/3 \u00a9 Reuters. FILE PHOTO: A vial labelled "CureVac COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. REUTERS\/Dado Ruvic\/Illustration\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ifintechworld.com\/?p=11557\" \/>\n<meta property=\"og:site_name\" content=\"iFintechWorld\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-21T03:41:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-21T03:41:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/05\/LYNXMPEA5Q0EZ_L.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"533\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ifintechworld.com\/?p=11557#article\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=11557\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\"},\"headline\":\"CureVac files expanded patent lawsuit against Pfizer\/BioNTech over mRNA technology\",\"datePublished\":\"2023-05-21T03:41:17+00:00\",\"dateModified\":\"2023-05-21T03:41:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=11557\"},\"wordCount\":242,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"keywords\":[\"Featured\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ifintechworld.com\/?p=11557#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ifintechworld.com\/?p=11557\",\"url\":\"https:\/\/ifintechworld.com\/?p=11557\",\"name\":\"CureVac files expanded patent lawsuit against Pfizer\/BioNTech over mRNA technology | iFintechWorld\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/#website\"},\"datePublished\":\"2023-05-21T03:41:17+00:00\",\"dateModified\":\"2023-05-21T03:41:18+00:00\",\"description\":\"3\/3 \u00a9 Reuters. FILE PHOTO: A vial labelled \\\"CureVac COVID-19 Vaccine\\\" is seen in this illustration taken January 16, 2022. REUTERS\/Dado Ruvic\/Illustration\",\"breadcrumb\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=11557#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ifintechworld.com\/?p=11557\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ifintechworld.com\/?p=11557#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ifintechworld.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CureVac files expanded patent lawsuit against Pfizer\/BioNTech over mRNA technology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ifintechworld.com\/#website\",\"url\":\"https:\/\/ifintechworld.com\/\",\"name\":\"Repay Down\",\"description\":\"Latest Personal Finance News, Tips and Updates\",\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ifintechworld.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ifintechworld.com\/#organization\",\"name\":\"Repay Down\",\"url\":\"https:\/\/ifintechworld.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"width\":558,\"height\":90,\"caption\":\"Repay Down\"},\"image\":{\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/ifintechworld.com\"],\"url\":\"https:\/\/ifintechworld.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CureVac files expanded patent lawsuit against Pfizer\/BioNTech over mRNA technology | iFintechWorld","description":"3\/3 \u00a9 Reuters. FILE PHOTO: A vial labelled \"CureVac COVID-19 Vaccine\" is seen in this illustration taken January 16, 2022. REUTERS\/Dado Ruvic\/Illustration","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ifintechworld.com\/?p=11557","og_locale":"en_US","og_type":"article","og_title":"CureVac files expanded patent lawsuit against Pfizer\/BioNTech over mRNA technology | iFintechWorld","og_description":"3\/3 \u00a9 Reuters. FILE PHOTO: A vial labelled \"CureVac COVID-19 Vaccine\" is seen in this illustration taken January 16, 2022. REUTERS\/Dado Ruvic\/Illustration","og_url":"https:\/\/ifintechworld.com\/?p=11557","og_site_name":"iFintechWorld","article_published_time":"2023-05-21T03:41:17+00:00","article_modified_time":"2023-05-21T03:41:18+00:00","og_image":[{"width":800,"height":533,"url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/05\/LYNXMPEA5Q0EZ_L.jpg","type":"image\/jpeg"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ifintechworld.com\/?p=11557#article","isPartOf":{"@id":"https:\/\/ifintechworld.com\/?p=11557"},"author":{"name":"News Room","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61"},"headline":"CureVac files expanded patent lawsuit against Pfizer\/BioNTech over mRNA technology","datePublished":"2023-05-21T03:41:17+00:00","dateModified":"2023-05-21T03:41:18+00:00","mainEntityOfPage":{"@id":"https:\/\/ifintechworld.com\/?p=11557"},"wordCount":242,"commentCount":0,"publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"keywords":["Featured"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ifintechworld.com\/?p=11557#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ifintechworld.com\/?p=11557","url":"https:\/\/ifintechworld.com\/?p=11557","name":"CureVac files expanded patent lawsuit against Pfizer\/BioNTech over mRNA technology | iFintechWorld","isPartOf":{"@id":"https:\/\/ifintechworld.com\/#website"},"datePublished":"2023-05-21T03:41:17+00:00","dateModified":"2023-05-21T03:41:18+00:00","description":"3\/3 \u00a9 Reuters. FILE PHOTO: A vial labelled \"CureVac COVID-19 Vaccine\" is seen in this illustration taken January 16, 2022. REUTERS\/Dado Ruvic\/Illustration","breadcrumb":{"@id":"https:\/\/ifintechworld.com\/?p=11557#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ifintechworld.com\/?p=11557"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ifintechworld.com\/?p=11557#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ifintechworld.com\/"},{"@type":"ListItem","position":2,"name":"CureVac files expanded patent lawsuit against Pfizer\/BioNTech over mRNA technology"}]},{"@type":"WebSite","@id":"https:\/\/ifintechworld.com\/#website","url":"https:\/\/ifintechworld.com\/","name":"Repay Down","description":"Latest Personal Finance News, Tips and Updates","publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ifintechworld.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ifintechworld.com\/#organization","name":"Repay Down","url":"https:\/\/ifintechworld.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","width":558,"height":90,"caption":"Repay Down"},"image":{"@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","caption":"News Room"},"sameAs":["https:\/\/ifintechworld.com"],"url":"https:\/\/ifintechworld.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/11557","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11557"}],"version-history":[{"count":1,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/11557\/revisions"}],"predecessor-version":[{"id":11559,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/11557\/revisions\/11559"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/media\/11558"}],"wp:attachment":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11557"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11557"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11557"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}